VTR Insider: Cafaro Executes Option Exercise and 10b5-1 Sale on Sept 2, 2025
Rhea-AI Filing Summary
Debra A. Cafaro, Chairman and CEO of Ventas, Inc. (VTR), exercised 10,322 fully vested stock options on 09/02/2025 at an exercise price of $65.45 per share and simultaneously sold the 10,322 underlying shares under a Rule 10b5-1 trading plan entered 03/28/2024. The sales generated a weighted average sale price of $67.8031 per share. After these transactions the reporting person beneficially owns 1,145,695 shares and holds 681,287 unexercised options. The filing was signed on 09/04/2025 by an attorney-in-fact.
Positive
- Transaction executed under a Rule 10b5-1 plan, indicating prearranged trading and procedural compliance
- Options exercised were fully vested, so the exercise did not accelerate unvested compensation
- Reporting person retains substantial stake with 1,145,695 shares beneficially owned and 681,287 unexercised options
Negative
- Insider sold 10,322 shares, reducing immediate economic exposure by the sold amount
- Options scheduled to expire within nine months were exercised, signaling limited remaining option duration
Insights
TL;DR: CEO exercised vested options and sold the resulting shares under a pre-established 10b5-1 plan; holdings remain substantial and no new compensation was disclosed.
The transaction reflects a routine exercise-and-sell of 10,322 options at an exercise price of $65.45 with sale proceeds achieved at a weighted average of $67.8031. Because the sale was executed pursuant to a Rule 10b5-1 plan established on 03/28/2024, the trade is a prearranged disposition rather than an ad hoc sale. The reporting person still beneficially owns 1,145,695 shares and retains 681,287 options, indicating continued significant economic interest.
TL;DR: Insider followed a documented 10b5-1 plan to exercise vested options and liquidate shares; filing is compliant and timely.
The disclosure shows adherence to a Rule 10b5-1 trading plan, which supports procedural compliance and reduces concerns about opportunistic timing. The exercise involved fully vested options scheduled to expire within nine months and the simultaneous sale was net of exercise price and taxes. The form is executed via attorney-in-fact and properly reports post-transaction beneficial ownership figures, enabling shareholders to assess insider stakes.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 10,322 | $0.00 | -- |
| Exercise | Common Stock | 10,322 | $65.45 | $676K |
| Sale | Common Stock | 10,322 | $67.8031 | $700K |
Footnotes (1)
- The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $67.4096 to $68.12, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Fully vested. Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person.
